Norris Perne & French LLP Opko Health, Inc. Transaction History

Norris Perne & French LLP

$1.3 Billion
Q2 2024

A detailed history of Norris Perne & French LLP transactions in Opko Health, Inc. stock. As of the latest transaction made, Norris Perne & French LLP holds 25,000 shares of OPK stock, worth $35,500. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,000

Previous 25,000 -0.0%

Holding current value

$35,500

Previous $30,000 3.33%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 19, 2023	BUY	$1.37 - $2.17 $6,850 - $10,850	5,000 Added 25.0%	25,000 $54,000
Q1 2023 Apr 20, 2023	SELL	$1.06 - $1.61 $39,220 - $59,570	-37,000 Reduced 64.91%	20,000 $29,000
Q4 2022 Jan 24, 2023	SELL	$1.05 - $2.01 $9,450 - $18,089	-9,000 Reduced 13.64%	57,000 $0
Q2 2022 Aug 11, 2022	SELL	$2.33 - $3.61 $2,330 - $3,610	-1,000 Reduced 1.49%	66,000 $167,000
Q3 2021 Oct 26, 2021	BUY	$3.44 - $4.24 $24,080 - $29,680	7,000 Added 11.67%	67,000 $245,000

Q1 2021 Apr 30, 2021	BUY	$4.19 - $5.99 $2,095 - $2,995	500 Added 0.84%	60,000 $257,000
Q4 2020 Jan 27, 2021	BUY	$3.27 - $4.87 $22,890 - $34,090	7,000 Added 13.33%	59,500 $235,000
Q3 2020 Oct 26, 2020	BUY	$2.99 - $5.96 $1,495 - $2,980	500 Added 0.96%	52,500 $194,000
Q2 2020 Jul 23, 2020	BUY	$1.15 - $3.41 $21,275 - $63,085	18,500 Added 55.22%	52,000 $177,000
Q1 2020 Apr 16, 2020	BUY	$1.34 - $2.32 $26,800 - $46,400	20,000 Added 148.15%	33,500 $45,000
Q4 2019 Jan 22, 2020	BUY	$1.42 - $2.17 $19,170 - $29,295	13,500 New	13,500 $20,000
Q4 2017 Jan 23, 2018	SELL	$4.61 - $7.04 $46,561 - $71,104	-10,100 Closed	0 $0
Q3 2017 Nov 01, 2017	BUY	$5.88 - $7.11 $59,388 - $71,811	10,100	10,100 $69,000

Others Institutions Holding OPK

# of Institutions

237

Shares Held

154M

Call Options Held

3.02M

Put Options Held

888K

View Full List

About OPKO HEALTH, INC.

Ticker OPK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 771,960,000
Market Cap $1.1B
Description
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...

More about OPK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norris Perne & French LLP, based on Form 13F filings with the SEC.

News

Stay updated on Norris Perne & French LLP with notifications on news.

Account

Norris Perne & French LLP Opko Health, Inc. Transaction History